Leronlimab in Combination With Regorafenib in Patients With CCR5+, Metastatic Colorectal Cancer
Clinical trial NCT05730673 · WITHDRAWN
Trial details
- NCT number
- NCT05730673
- Sponsor
- CytoDyn, Inc.
- Status
- WITHDRAWN
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2022-09-20
- Primary completion
- 2023-05-27
- Enrollment
- 0
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.